Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
66.35
-1.44 (-2.12%)
Nov 21, 2025, 3:04 PM CST
65.88%
Market Cap17.58B
Revenue (ttm)1.47B
Net Income (ttm)123.17M
Shares Out264.98M
EPS (ttm)0.47
PE Ratio141.22
Forward PE91.52
Dividendn/a
Ex-Dividend Daten/a
Volume4,558,900
Average Volume8,627,094
Open72.55
Previous Close67.79
Day's Range66.10 - 72.55
52-Week Range26.61 - 90.68
Beta-0.49
RSI40.17
Earnings DateOct 29, 2025

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instrument... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 867
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.

Financial Statements

News

There is no news available yet.